Cargando…
Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas.
Decay-accelerating-factor (DAF, CD55), a phosphatidyl-inositol anchored glycoprotein, is a member of the cell membrane bound complement regulatory proteins that inhibit autologous complement cascade activation. DAF was found expressed on cells that are in close contact with serum complement proteins...
Autores principales: | Koretz, K., Brüderlein, S., Henne, C., Möller, P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977964/ https://www.ncbi.nlm.nih.gov/pubmed/1384641 |
Ejemplares similares
-
Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium.
por: Koretz, K., et al.
Publicado: (1993) -
Bee Venom Alleviates Atopic Dermatitis Symptoms through the Upregulation of Decay-Accelerating Factor (DAF/CD55)
por: Kim, Yenny, et al.
Publicado: (2019) -
Discovery, linkage disequilibrium and association analyses of polymorphisms of the immune complement inhibitor, decay-accelerating factor gene (DAF/CD55) in type 1 diabetes
por: Taniguchi, Hidenori, et al.
Publicado: (2006) -
Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55)
Publicado: (1996) -
The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo
por: Liu, Jianuo, et al.
Publicado: (2005)